XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
149 hedge funds and large institutions have $1.47B invested in Acceleron Pharma in 2017 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 128 → 149 (+21)
78% less call options, than puts
Call options by funds: $2.48M | Put options by funds: $11.5M
Holders
149
Holding in Top 10
6
Calls
$2.48M
Puts
$11.5M
Top Buyers
| 1 | +$35.9M | |
| 2 | +$33.8M | |
| 3 | +$31M | |
| 4 |
DM
Deerfield Management
New York
|
+$23M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20M |
Top Sellers
| 1 | -$37.5M | |
| 2 | -$25.9M | |
| 3 | -$12.1M | |
| 4 |
Millennium Management
New York
|
-$6.87M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.25M |